Novel gemcitabine-containing triplets in the management of urothelial cancer

被引：10
作者：
Hussain, M
Vaishampayan, U
Smith, DC
机构：
[1] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA
[2] Barbara Ann Karmanos Canc Inst, Detroit, MI USA
[3] Wayne State Univ, Div Hematol Oncol, Detroit, MI 48202 USA
来源：
SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 01期
关键词：
D O I：
10.1053/sonc.2002.30753
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 24
页数：5
相关论文
共 15 条
  • [1] Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium
    Bellmunt, J
    Guillem, V
    Paz-Ares, L
    González-Larriba, JL
    Carles, J
    Batiste-Alentorn, E
    Sáenz, A
    López-Brea, M
    Font, A
    Nogué, M
    Bastús, R
    Climent, MA
    de la Cruz, JJ
    Albanell, J
    Banús, JM
    Gallardo, E
    Diaz-Rubio, E
    Cortés-Funes, H
    Baselga, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (18) : 3247 - 3255
  • [2] Phase I evaluation of sequential doxorubicin plus gemcitabine then ifosfamide plus paclitaxel plus cisplatin for patients with unresectable or metastatic transitional-cell carcinoma of the urothelial tract
    Dodd, PM
    McCaffrey, JA
    Hilton, S
    Mazumdar, M
    Herr, H
    Kelly, WK
    Icasiano, E
    Boyle, MG
    Bajorin, DF
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (04) : 840 - 846
  • [3] Phase II study of cisplatin and paclitaxel in advanced carcinoma of the urothelium: An Eastern Cooperative Oncology Group study
    Dreicer, R
    Manola, J
    Roth, BJ
    Cohen, MB
    Hatfield, AK
    Wilding, G
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (05) : 1058 - 1061
  • [4] HOVEY EJ, 2000, P AN M AM SOC CLIN, V19, pA350
  • [5] Combination paclitaxel, carboplatin, and gemcitabine is an active treatment for advanced urothelial cancer
    Hussain, M
    Vaishampayan, U
    Du, W
    Redman, B
    Smith, DC
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (09) : 2527 - 2533
  • [6] Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer
    Kaufman, D
    Raghavan, D
    Carducci, M
    Levine, EG
    Murphy, B
    Aisner, J
    Kuzel, T
    Nicol, S
    Oh, W
    Stadler, W
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (09) : 1921 - 1927
  • [7] LINDNER H, 2000, P AN M AM SOC CLIN, V19, pA353
  • [8] Gemcitabine plus cisplatin for advanced transitional cell carcinoma of the urinary tract: A phase II multicenter trial
    Lorusso, V
    Manzione, L
    De Vita, F
    Antimi, M
    Selvaggi, FP
    De Lena, M
    [J]. JOURNAL OF UROLOGY, 2000, 164 (01) : 53 - 56
  • [9] Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: A phase II trial of the National Cancer Institute of Canada clinical trials group
    Moore, MJ
    Winquist, EW
    Murray, N
    Tannock, IF
    Huan, S
    Bennett, K
    Walsh, W
    Seymour, L
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2876 - 2881
  • [10] Raghavan D, 2000, Eur J Cancer, V36 Suppl 2, P1, DOI 10.1016/S0959-8049(00)00075-7
12